Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Expression of prostate specific membrane antigen |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| C/D (optional) |
| Level of Evidence |
| no clear evidence-based recommendation |
| Effective Dose |
| 20.0 µSv/MBq |
| Bibliographic Reference |
|
Emmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M.J., Rasiah, K., Pattison, D.A., Yaxley, J., Thomas, P., Hutton, A.C., Agrawal, S....
read more
Emmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M.J., Rasiah, K., Pattison, D.A., Yaxley, J., Thomas, P., Hutton, A.C., Agrawal, S., Amin, A., Blazevski, A., Chalasani, V., Ho, B., Nguyen, A., Liu, V., Lee, J., Sheehan-Dare, G., Kooner, R., Coughlin, G., Chan, L., Cusick, T., Namdarian, B., Kapoor, J., Alghazo, O., Woo, H.H., Lawrentschuk, N., Murphy, D., Hofman, M.S., Stricker, P. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study. Eur Urol. 2021.
read less
|
| Guide to Nuclear Medicine |
| Read the corresponding chapter |